Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network …

J Mutz, V Vipulananthan, B Carter, R Hurlemann… - bmj, 2019 - bmj.com
Objective To estimate the comparative clinical efficacy and acceptability of non-surgical
brain stimulation for the acute treatment of major depressive episodes in adults. Design …

Efficacy and acceptability of non-invasive brain stimulation for the treatment of adult unipolar and bipolar depression: a systematic review and meta-analysis of …

J Mutz, DR Edgcumbe, AR Brunoni, CHY Fu - … & Biobehavioral Reviews, 2018 - Elsevier
We examined the efficacy and acceptability of non-invasive brain stimulation in adult
unipolar and bipolar depression. Randomised sham-controlled trials of transcranial direct …

Efficacy and acceptability of transcranial direct current stimulation (tDCS) for major depressive disorder: An individual patient data meta-analysis

AH Moffa, D Martin, A Alonzo, D Bennabi… - Progress in Neuro …, 2020 - Elsevier
We evaluated the efficacy and acceptability of transcranial direct current stimulation (tDCS)
for treating acute depressive episodes using individual patient data that provide more …

Comparative efficacy and acceptability of electroconvulsive therapy versus repetitive transcranial magnetic stimulation for major depression: a systematic review and …

J Chen, L Zhao, Y Liu, S Fan, P Xie - Behavioural Brain Research, 2017 - Elsevier
Backgrounds The effects of electroconvulsive therapy (ECT) and bilateral, left prefrontal, and
right prefrontal repetitive transcranial magnetic stimulation (rTMS) on major depressive …

[HTML][HTML] Efficacy and safety of transcranial magnetic stimulation for treating major depressive disorder: An umbrella review and re-analysis of published meta-analyses …

S Brini, NI Brudasca, A Hodkinson, K Kaluzinska… - Clinical psychology …, 2023 - Elsevier
Objectives We re-analysed data from published meta-analyses testing the effects of
Transcranial Magnetic Stimulation (TMS) on Major Depressive Disorder (MDD) in adults. We …

Repetitive transcranial magnetic stimulation for the acute treatment of major depressive episodes: a systematic review with network meta-analysis

AR Brunoni, A Chaimani, AH Moffa, LB Razza… - JAMA …, 2017 - jamanetwork.com
Importance Although several strategies of repetitive transcranial magnetic stimulation (rTMS)
have been investigated as treatment of major depressive disorder (MDD), their comparative …

Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults.: IV. Neurostimulation …

SH Kennedy, R Milev, P Giacobbe… - Journal of affective …, 2009 - Elsevier
BACKGROUND: In 2001, the Canadian Psychiatric Association and the Canadian Network
for Mood and Anxiety Treatments (CANMAT) partnered to produce evidence-based clinical …

Follow-up effects of transcranial direct current stimulation (tDCS) for the major depressive episode: a systematic review and meta-analysis

LB Razza, S De Smet, A Moffa, P Sudbrack-Oliveira… - Psychiatry …, 2021 - Elsevier
Abstract Transcranial Direct Current Stimulation (tDCS) is an effective treatment during the
acute phase of a major depressive episode (MDE), although the evidence for its follow-up …

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 4 …

RV Milev, P Giacobbe, SH Kennedy… - The Canadian …, 2016 - journals.sagepub.com
Background: The Canadian Network for Mood and Anxiety Treatments (CANMAT)
conducted a revision of the 2009 guidelines by updating the evidence and …

[HTML][HTML] The clinical TMS society consensus review and treatment recommendations for TMS therapy for major depressive disorder

T Perera, MS George, G Grammer, PG Janicak… - Brain stimulation, 2016 - Elsevier
Abstract Background Prefrontal Transcranial Magnetic Stimulation (TMS) therapy repeated
daily over 4–6 weeks (20–30 sessions) is US Food and Drug Administration (FDA) approved …